ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $259,000 | -4.1% | 6,410 | +36.7% | 0.00% | 0.0% |
Q2 2015 | $270,000 | +18.4% | 4,688 | +30.9% | 0.00% | 0.0% |
Q1 2015 | $228,000 | +3.6% | 3,580 | +0.4% | 0.00% | 0.0% |
Q4 2014 | $220,000 | +40.1% | 3,566 | -11.6% | 0.00% | +100.0% |
Q3 2014 | $157,000 | +3.3% | 4,033 | -8.4% | 0.00% | 0.0% |
Q2 2014 | $152,000 | -23.2% | 4,402 | -4.1% | 0.00% | -50.0% |
Q1 2014 | $198,000 | +15.8% | 4,590 | +6.6% | 0.00% | +100.0% |
Q4 2013 | $171,000 | -65.7% | 4,304 | -67.6% | 0.00% | -75.0% |
Q3 2013 | $498,000 | +144.1% | 13,278 | +74.6% | 0.00% | +100.0% |
Q2 2013 | $204,000 | – | 7,606 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |